Skip to main content
For Healthcare Professionals
Banner-Background

OVERVIEW

JASCAYD® offers simple, twice-daily oral dosing1

The recommended dose is 18 mg twice daily
Timing
Timing

Take 1 tablet, 12 hours apart (morning and evening)

Administration
Administration

Take with or without food

Adjustable
Adjustable

Based on individual patient tolerability of certain adverse reactions (diarrhea, weight loss), the dosage may be reduced to 9 mg twice daily

Missed dose
Missed dose

Resume at the next scheduled time with recommended dose

No liver or lab monitoring required at treatment initiation

CONCOMITANT USE

Dosage modification of JASCAYD® for concomitant use

Strong CYP3A inhibitors: The dosage of JASCAYD® must be reduced to 9 mg twice daily.

Strong or moderate CYP3A inhibitors (and pirfenidone): The recommended dosage of JASCAYD® is 18 mg twice daily and must NOT be reduced to 9 mg twice daily.

Reference

  1. JASCAYD® UAE Local SmPC; May 2026.

MLR ID: PC-AE-102896
Expiry Date: 10/05/2028